Evidence map›Paper›PMID 32274125›Full record

ArticleJournal of thoracic disease2020

Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.

Yue Yu, Renhong Huang, Pei Wang, Suyu Wang, Xinyu Ling, Peng Zhang, Jingwen Yu, Jun Wang, Jian Xiao, Zhinong Wang

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Physiological pattern differences in non-intubatedJournal of thoracic disease · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yue YuDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Renhong HuangDepartment of General Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Pei WangDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Suyu WangDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Xinyu LingDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Peng ZhangDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Jingwen YuDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Jun WangDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Jian XiaoDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Zhinong WangDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Second Military Medical University · CNShanghai Changzheng Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe optimal surgical strategy for early-stage non-small cell lung cancer (NSCLC) with visceral pleural invasion (VPI) remains unclear. Due to limited prospective comparative data for these surgical modalities, the objective of the current study was to compare the long-term survival outcomes of sublobectomy (Sub) versus lobectomy (Lob) for NSCLC with a tumor size ≤2 cm and VPI.

methodsPatients with early-stage NSCLC characterized by VPI diagnosed between 2004 and 2013 were identified from the Surveillance, Epidemiology, and End Results (SEER) program. The baseline demographic and cancer characteristics, treatment information as well as survival outcome data were extracted from the SEER database, and confounders were balanced by propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) analyses. Lung disease-specific survival (DSS) and overall survival (OS) rates were compared with Cox proportional hazards (PH) regression models based on the unmatched cohort, the propensity-based matched cohort, and the IPTW cohort.

resultsOf the 1,386 patients enrolled, 1,000 (72.15%) and 386 (27.85%) underwent lobectomy and sublobectomy, respectively. The 5-year DSS rate was 78.64% for the lobectomy group and 59.47% for the sublobectomy group. Cox regression models demonstrated that the operation type (Sub

conclusionsLobectomy showed superior long-term survival compared with sublobectomy in patients with early-stage NSCLC with a tumor size ≤2 cm and VPI.

Indexed as

lobectomy (Lob)Non-small cell lung cancer (NSCLC)SEER databasesublobectomy (Sub)visceral pleural invasion (VPI)

Identifiers

PMID32274125
PMCPMC7138986
OpenAlexW3006595887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.